Amgen Inc. - Company & Market Research Reports

Home /
Companies /
Amgen Inc.

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 335
Immune Disorders Drugs 209
Biopharmaceuticals 178
Musculoskeletal Disorders Drugs 126
Genomics 115
Cardiovascular Drugs 106
Biotechnology 83
Pharmaceuticals 80
Drug Discovery 78
Endocrine and Metabolic Disorders Drugs 77
Biosimilars and Biosuperiors 72
Allergy and Immunology 67
Leukemia Drugs 64
Infusions and Injectables 63
Hematological Drugs 61
Oncology 52
Clinical Trials 51
Dermatological Drugs 50
Central Nervous System Drugs 49
Liver and Kidney Disorders Drugs 45
Women's Health 44
Needles and Syringes 40
Drug Delivery 38
Psoriasis Drugs 37
Diagnostics 36
Skin Cancer Drugs 35
Hematology 29
Infectious Diseases Drugs 28
Brain Cancer Drugs 28
Proteomics 27
Enzymes 27
Gastrointestinal Drugs 27
Lung Cancer Drugs 26
Colon Cancer Drugs 26
Analgesics 24
Immunosuppressive Drugs 24
Lymphoma Drugs 23
Pharmaceutical Manufacturing 19
Drugs by Therapeutic Area 18
Dermatology 18
Optical 17
Therapeutic Area 16
Urology and Nephrology 15
Healthcare Services 15
Respiratory Drugs 15
Kidney Cancer Drugs 14
Optical Disorders Drugs 13
Pancreatic Cancer Drugs 12
Nanomedicine 11
Generic Drugs 10
Breast Cancer Drugs 10
Prostate Cancer Drugs 10
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Cardiology 10
Sexual and Reproductive Health Drugs 10
E-Healthcare 9
Liver Cancer Drugs 8
Cancer Vaccines 8
Other Healthcare Facilities 8
Gastroenterology 8
Pulmonary Medicine 7
In Vitro Diagnostics 7
Biomarkers 7
Anti-Obesity Drugs 7
Neurology 6
Diabetes Drugs 6
Biomaterials 6
Vaccines 6
Mental Disorders Drugs 6
Company Reports 5
Animal Pharmaceuticals 5
Medical Devices 5
Molecular Diagnostics 5
Over the Counter (OTC) Drugs 5
Pediatrics 5
Asthma Drugs 5
Pharmaceutical Intermediates 4
Surgical Procedures 4
Thyroid Cancer Drugs 4
Alzheimer's Disease Drugs 4
Managed Care 3
Stem Cells 3
Endocrinology 3
Addiction Disorders Drugs 2
Bladder Cancer Drugs 2
Cardiovascular Devices 2
Infectious Disease Testing 2
Inhalers and Nebulisers 2
Mental Health 2
Uterine Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Antibiotics 2
Acne Drugs 2
Urological Disorders Drugs 2
Schizophrenia Drugs 2
Hepatology 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Orthopedic Devices 1
Cholesterol Testing 1
Cough and Cold Drugs 1
Healthcare 1
Radiography 1
Transdermal and Transmucosal Drug Delivery 1
Blood Banking 1
Hospital Management 1
Respiratory Devices 1
Clinical Therapies 1
Clinical Skills 1
Palliative Care 1
Anatomy 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



284 reviews

2,092 Results (Page 18 of 105)
- Relevance
  Sort by

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

 Report
March 2025
1048 Pages
Global

From

€4292EUR$4,799USD£3,669GBP

Patient Recruitment Services and Patient Retention Services Market by Patient Recruitment Step, Trial Phase Therapeutic Area and Key Geographies, Industry Trends and Global Forecasts, 2022-2035

 Report
October 2022
185 Pages
Global

From

€4292EUR$4,799USD£3,669GBP

Chemotherapy-Induced Neutropenia (CIN) Treatment Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

 Report
August 2022
113 Pages
Global

From

€4248EUR$4,750USD£3,632GBP

Osteoporosis Therapeutics - Global Strategic Business Report

 Report
August 2026
340 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Self-Injection Devices Market - Global Strategic Business Report

 Report
August 2026
383 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Autoinjectors - Global Strategic Business Report

 Report
August 2026
483 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Cancer Active Pharmaceutical Ingredients (APIs) Market - Global Strategic Business Report

 Report
August 2026
466 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Immuno-Oncology - Global Strategic Business Report

 Report
August 2026
246 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Desmoid Tumors Market - Global Strategic Business Report

 Report
August 2026
286 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Gastric Cancer Market - Global Strategic Business Report

 Report
August 2026
582 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Precision Oncology Market - Global Strategic Business Report

 Report
August 2026
382 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Pituitary Cancer Market - Global Strategic Business Report

 Report
August 2026
575 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report

 Report
August 2026
173 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Cellular Immunotherapy - Global Strategic Business Report

 Report
August 2026
386 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Oncolytic Virus Immunotherapy Market - Global Strategic Business Report

 Report
August 2026
383 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Monoclonal Antibodies - Global Strategic Business Report

 Report
August 2026
462 Pages
Global

From

€5232EUR$5,850USD£4,473GBP

Ependymoma Drug Market - Global Forecast 2026-2032

 Report
January 2026
192 Pages
Global

From

€3170EUR$3,545USD£2,711GBP

€3523EUR$3,939USD£3,012GBP

Inlyta (axitinib; Pfizer) Drug Overview 2019

 Report
March 2019
20 Pages
Global

€8943EUR$10,000USD£7,646GBP

US Axial Spondyloarthritis Market outlook to 2028

 Report
October 2023
85 Pages
United States

From

€4024EUR$4,500USD£3,441GBP

Breast Cancer Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4015EUR$4,490USD£3,433GBP

2,092 Results (Page 18 of 105)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.